Pharmaids Pharmaceuticals Ltd share price was up by 1.63% from the previous closing price of ₹37.97. Who are peers of Pharmaids Pharmaceuticals Ltd? The peers of Pharmaids Pharmaceuticals Ltd ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Q2 results season is coming to an end; the entire month of October was packed with giants from every sector declaring ...

Other notable companies announcing earnings on Wednesday include Kalyan Jewellers, Garden Reach Shipbuilders, Vodafone Idea, ...

During the preclinical stage, the focus of forecasting is not necessarily on the product itself, but on the broader opportunity within the disease area. At this point, there is limited information ...

Manufacture and commercially distribute its prescription pharmaceutical SCENESSE in the European Union and the USA for the treatment of the rare, genetic metabolic disorder EPP, research and ...

According to the BSE website, among Alkem Laboratories, Apollo Tyres, Arkade Developers, Balkrishna Paper, Borosil, Century ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...

Acadia Pharmaceuticals said it is selling its rare pediatric disease priority review voucher for $150 million. The biotechnology company on Tuesday said it plans to invest the proceeds from the sale ...